Background Established in 2000, Millennium Development Goal 4 (MDG4) catalysed extraordinary political, fi nancial, and social commitments to reduce under-5 mortality by two-thirds between 1990 and 2015. At the country level, the pace of progress in improving child survival has varied markedly, highlighting a crucial need to further examine potential drivers of accelerated or slowed decreases in child mortality. The Global Burden of Disease 2015 Study (GBD 2015) provides an analytical framework to comprehensively assess these trends for under-5 mortality, age-specifi c and cause-specifi c mortality among children under 5 years, and stillbirths by geography over time.
Introduction
Substantial reductions in under-5 mortality have occurred worldwide during the past 35 years, with every region recording sizeable improvements in child survival. [1] [2] [3] [4] [5] [6] [7] [8] National rates of decrease have varied substantially, 1,5 which has been attributed to rising levels of income per person; 9, 10 greater educational attainment, especially in women of reproductive age; 11, 12 lower fertility rates; strengthened public health programmes; and overall improvements in health technologies and systems. 13 Many view the development and scale-up of many life-saving interventions targeting various leading causes of under-5 deaths 14 as primary accelerants of child survival during this time, including insecticidetreated nets, 15, 16 artemisinin-based combination therapies, 17 the prevention of mother-to-child transmission of HIV, 18 and a number of vaccines, such as for measle s and rotavirus and the pneumococcal conjugate vaccine. 19 Further, expanding the provision of more long-standing inter ventions, such as oral rehydration therapy for diarrhoeal diseases or antibiotics for pneumonia, and addressing environmental risks, such as water and sanitation, probably contributed to reductions in under-5 mortality in many places. 20, 21 Amid such advances were increased domestic funding and development assistance for health, particularly Interpretation Gains in child survival have been large, widespread, and in many places in the world, faster than what was anticipated based on improving levels of development. Yet some countries, particularly in sub-Saharan Africa, still had high rates of under-5 mortality in 2015. Unless these countries are able to accelerate reductions in child deaths at an extraordinary pace, their achievement of proposed SDG targets is unlikely. Improving the evidence base on drivers that might hasten the pace of progress for child survival, ranging from cost-eff ective intervention packages to innovative fi nancing mechanisms, is vital to charting the pathways for ultimately ending preventable child deaths by 2030.
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Research in context
Evidence before this study The Global Burden of Disease (GBD) study has a long history of generating comprehensive, comparable estimates of child mortality, and has continually refi ned current methods or developed new analytical approaches to maximise a full range of data sources and systems that track child survival. For the 2013 iteration of GBD, we evaluated the relative contributions of diff erent factors, including number of births and education levels, to changes in under-5 mortality from 2000 to 2013. In recent years, several studies have sought to assess drivers of changes in child mortality, such as postulating trends caused by a subset of causes and indicators of technical progress. A shortcoming of these past approaches is that estimates of under-5 mortality levels and trends are typically produced within separate analytical frameworks, rather than unifi ed estimation systems. GBD 2015 child mortality analyses feature several advances from previous rounds of the GBD, including an expanded set of territories and subnational geographies, additional causes, and critical examinations on the measurement and impact of changes in sociodemographic status on child survival.
Added value of this study
The GBD assessment of child mortality provides timely, robust evidence on documenting child health achievements during the Millennium Development Goal era, identifying causes and regions for which less progress occurred, and characterising the association between improving development and child survival. Estimates of child mortality by age (neonatal, post-neonatal, 1-4 years, and under-5) , sex, and cause over time now include 519 geographies, a notable increase from the 264 included in GBD 2013. The under-5 mortality database has increased greatly since GBD 2013, and we implemented several methodological improvements, including data bias adjustments by data source and data type. For the fi rst time, we estimated the number and rates of stillbirths across geographies and over time. Further, this analysis applies measures of Socio-demographic Index (SDI), a composite measure of income per person, educational attainment, and fertility for every geography year, to examine the association between changes in child mortality and improving levels of development.
Implications
This study provides the most comprehensive assessment so far of levels and trends of child mortality worldwide, linking recorded rates of change in under-5 mortality with expected rates of decrease based on SDI alone. Through a series of decomposition analyses, we identify which groups of causes contribute most to reductions in under-5 mortality across regions and the development spectrum. Comparisons of recorded levels and cause composition for child mortality with patterns expected based on SDI alone off er an in-depth, nuanced picture of where countries might need to refocus policies and resource allocation for accelerated improvements in child survival in the future. resources dedicated to child health. 22, 23 The Millennium Declaration 24 and the political and technical focus catalysed by Millennium Development Goal 4 (MDG4), arguably incited heightened policy attention and fi nancial commitments to child health by national governments and development partners alike.
Despite such progress, most low-income and middleincome countries (LMICs) did not achieve the MDG4 target of reducing under-5 mortality by two-thirds between 1990 and 2015, which equates to a 4·4% annualised rate of decrease during this time. 5 From 1990 to 2000, the global rate of decrease for under-5 mortality averaged 2·0% (1·7-2·4) per year, and previous forecasts by the UN Inter-agency Group for Child Mortality Estimation (IGME) suggested that 62 of 195 countries would achieve MDG4 by 2015.
5 Further, at the global level, IGME estimated that MDG4 would be missed by 14 percentage points (ie, a 53% decrease in under-5 mortality between 1990 and 2015). The degree to which countries diverged in their pace of progress has prompted extensive debate and refl ection on the various drivers of child health, including absolute and relative funding levels, 25 overarching governance, 26 health-system effi ciencies, 27 and implementation of optimum intervention packages and specifi c health programmes. 13, 28 Further, the relative eff ect of gains in sociodemographic status, advances in medical technologies, and reductions in cause-specifi c mortality remains contested. Previous studies postulate the eff ects of cause-specifi c death patterns on national trends in under-5 mortality, 7, 29 and others have sought to isolate the eff ect of broader factors, including income per person and education. 30 However, few studies, if any, have systematically attributed changes in mortality due to leading causes of child deaths, as well as gains in overall development, across geographies and over time.
Enhanced estimation methods, as well as increased quantity and quality of data, not only show large disparities in under-5 mortality across and within countries, 1, 5, 31, 32 but also emphasise distinct variations in survival by age group and cause among children younger than 5 years. 1, 14, 33, 34 Previous studies report much slower decreases in mortality rates for neonates, or children younger than 28 days, than those recorded for post-neonates and children aged 1 to 4 years. 1, 33 These fi ndings have prompted a heighted focus on newborn health, 35 especially around the types of interventions and health services that might accelerate reductions in neonatal mortality. [36] [37] [38] Systematic disaggregation of levels and trends in neonatal mortality, particularly at subnational levels, can help focus local needs and strategies for improving newborn health. Recent analyses also bring renewed attention to late fetal and intrapartum deaths, known as stillbirths. 39, 40 Especially in low-income areas, higher stillbirth rates have been associated with preventable maternal infections, including malaria and syphilis, 40 highlighting the importance of using a comprehensive analytic approach that can account for or link various exposures and socioeconomic factors related to stillbirths. In combination, these fi ndings underscore the vital need to advance understanding of fetal risks and causes of early death associated with pregnancy or delivery across and within populations.
In 2015, the MDGs were replaced by the more all-encompassing, albeit less health-focused, Sustainable Development Goals (SDGs). 41 SDG3.2 is the main indicator for improving child survival, with targets of reducing under-5 mortality to fewer than 25 deaths per 1000 livebirths, decreasing neonatal mortality to fewer than 12 deaths per 1000 livebirths, and ending preventable deaths of newborns and children younger than 5 years, all by 2030. In view of these ambitious global goals, and the highly heterogeneous trends recorded in absolute and relative child mortality trends in the past, it is crucial to comprehensively assess factors that aff ected mortality trends in the past and to identify which ones might further improve child survival in the future.
The 2015 iteration of the Global Burden of Diseases, Injuries, and Risk Factors Study (GBD 2015) provides the analytical framework from which reductions in child mortality can be thoroughly examined by age, geography, and cause over time. For GBD 2015, we analyse rates of under-5 mortality disaggregated by age group, as well as stillbirths, for 195 countries and territories from 1980 to 2015; however, much of this paper focuses on results between 1990 and 2015, aligning with the period of time covered by MDG4. Expanding on subnational analyses done for GBD 2013, we provide estimates of levels and trends in under-5 mortality at subnational levels for Brazil, China, India, Japan, Kenya, Mexico, Saudi Arabia, South Africa, Sweden, the UK, and the USA. Through a series of decomposition analyses and assessments of child mortality in relation to measures of sociodemographic status, we quantify diff erences in observed and expected gains in child survival given changes in development alone.
Methods
The methods used to generate estimates of under-5 mortality and age-specifi c death rates (early neonatal, late neonatal, post-neonatal, ages 1-4 years, infant, and under 5), contribute to broader GBD 2015 analyses and results on all-cause mortality and cause of death. Substantial detail on data inputs, processing, and estimation methods can be found in an accompanying GBD 2015 publication.
14 Here we provide a brief summary of our under-5 mortality estimation approach and accompanying analyses, including an assessment of mortality trends by Soci-demographic Index (SDI), and attribute changes in under-5 mortality to leading causes of death. We also describe our estimation of stillbirths by geography and over time.
Stillbirths
Early neonatal (0-6 days)
Late neonatal 
95% UIs are provided in parentheses. UI=uncertainty intervals. 42 which include the documentation of data sources and inputs, processing and estimation steps, and overarching methods used throughout the GBD study.
Geographical units of analysis
For GBD 2015, we analysed 195 countries and territories in the 21 GBD regions. Since GBD 2013, we added seven territories and expanded subnational analyses from three countries (China, Mexico, and the UK) [43] [44] [45] to include eight additional countries: Brazil, India, Japan, Kenya, Saudi Arabia, South Africa, Sweden, and the USA. Here, we present results at the global, regional, national, territory, and, for a subset of countries, subnational levels from 1980-2015. Countries for which subnational estimates are shown include Brazil (26 states and one district), China (33 provinces and municipalities), India (62 urban and rural administrative units), Japan (47 prefectures), Kenya (47 counties), Mexico (32 states), Saudi Arabia (13 regions), South Africa (nine provinces), Sweden (two regions), the UK (four nations and nine subregions for England), and the USA (50 states and the District of Columbia).
Data
Data sources and types used for estimating child mortality are described extensively elsewhere, 14 but in sum, vital registration (VR) systems, censuses, and household surveys with complete or summary birth histories served as primary inputs for our analyses. Other sources, including sample registration systems and disease surveillance systems, also contributed as input data. In total we applied formal demographic techniques to 8169 input data sources of under-5 mortality from 1950-2015. Overall data availability and availability by source data type varied by geography.
Stillbirth data were extracted from major survey series, including Demographic and Health Surveys, the Centers for Disease Control & Prevention (CDC) Reproductive Health Surveys, UNICEF Multiple Indicator Cluster Surveys, and the WHO Multi-Country Surveys. We also used VR systems, birth registries, and literature sources. Following defi nitions for stillbirths used by previous studies, 39, 40 we classifi ed fetal deaths at 28 weeks or later and intrapartum deaths (ie, deaths that occurred after the onset of labour but prior to birth) as stillbirths. We collated 7579 geography-year datapoints from 1980-2015 on stillbirths, representing 350 countries, territories, and subnational locations in our analysis. The appendix provides additional detail on stillbirth data sources and processing steps (appendix pp [19] [20] [21] [22] .
All-cause under-5 mortality and age-specifi c mortality
The appendix presents the analytical steps involved in estimating all-cause under-5 mortality and death rates by age group: early neonatal (0-6 days), late neonatal (7-28 days) , post-neonatal (29-364 days) , and ages 1-4 years (appendix p 31). Details on data bias adjustments for under-5 mortality, using spatiotemporal Gaussian Process regression to generate a complete time series of under-5 mortality for all geographies and the age-sex model to produce estimates of mortality for early neonatal, late neonatal, post-neonatal, and ages 1-4 years have been extensively discussed previously 46 and in the appendix.
For subnational analyses, we rescaled estimates from lower administrative units to the national level because data densities were generally much higher at the national level than at the subnational. South Africa was the exception to this approach, where national-level estimates were generated by aggregating subnational estimates up to the national level.
To estimate mortality by age group and sex within the under-5 categorisation, we used a two-stage modelling process that has been described in detail elsewhere. 3, 14 For this analysis, we report on early neonatal and late neonatal mortality results in aggregate as neonatal mortality; the appendix provides estimates of early and late neonatal mortality (appendix pp 35, 36) .
Stillbirth analysis
In GBD 2015, for the fi rst time, we generated estimates of stillbirths and stillbirth rates by location from 1980-2015. Drawing from data compiled by Blencowe and colleagues, 39 we expanded to include additional data from published literature, VR, and surveys. We estimated stillbirth trends by modifying the data synthesis model used for under-5 mortality. We applied a mixed-eff ects generalised linear model to quantify the ratio of stillbirth rates to neonatal mortality in natural logarithmic space. Our model covariates included educational attainment among women of reproductive age, skilled birth attendance, a random eff ect on neonatal mortality classifi ed into 20 bins, random intercepts for each location, and data source-specifi c random eff ects nested within each location. Neonatal mortality was chosen for its strong coeffi cient of correlation with stillbirth rates (0·8). Source-specifi c fi xed eff ects were included to adjust for biases inherent to a subset of data sources; the appendix provides the complete list of data source types (appendix p 21). Finally, we included a variable that accounted for diff erent stillbirth defi nitions, encompassing the seven defi nitions found within our database. These defi nitions included fetal death after 28 weeks of gestation, 26 weeks of gestation, 24 weeks of gestation, 22 weeks of gestation, 20 weeks of gestation, weighing at least 1000 g, and weighing at least 500 g. There were also 1744 location-years where no defi nition was provided, which we included as an eighth undefi ned defi nition category. Stillbirth rates from surveys and complete vital registration systems where the defi nition of stillbirth Under 5 1990 Under 5 -2000 Under 5 2000 Under 5 -15 1990 Under 5 -2015 (Continued from previous page)
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São Tomé and Príncipe was fetal death after 28 weeks of gestation were used as reference sources in the data bias adjustment process. Other non-reference sources were adjusted based on data source fi xed eff ects for surveys or complete VR and data source-specifi c random eff ects. The appendix provides additional details on the modelling process (appendix pp [20] [21] [22] .
Under-5 populations and total deaths
Accurate estimates of total under-5 deaths hinge upon accurate estimates of under-5 populations, disaggregated by each age group, sex, geography, and year. For each age-sex-specifi c group, we modelled population as a function of livebirths for every year and corresponding death rates during each interval under analysis. 
*Geographies that achieved MDG4 based on a greater than 4·4% annualised rate of decline in under-5 mortality between 1990 and 2015. 95% UIs are provided in parentheses. MDG4=Millennium Development Goal 4. UIs=uncertainty intervals. The appendix provides population estimates (appendix pp 93-104).
Under-5 causes of death
The methods developed and used in GBD 2015, including the systematic approach to collating causes of death from diff erent countries, mapping across diff erent revisions and national variants of the International Classifi cation of Diseases and Injuries (ICD); redistribution of deaths assigned to so-called garbage codes; and the overall and disease-specifi c cause of death modelling approaches are described in other publications 14, [47] [48] [49] [50] and in the appendix (appendix pp 24, 25) .
For GBD 2015, we assessed 249 causes of death across age groups. Because of cause-specifi c age restrictions (eg, no child deaths due to Alzheimer's disease and other dementias), not all causes of death were applicable for children younger than 5 years. The appendix provides the full GBD 2015 cause list (appendix pp 150-56), and additional information is published elsewhere.
14,51
Socio-demographic Index
Expanding upon analyses from GBD 2013, 52 we studied patterns in child mortality as they related to measures of socioeconomic status and development. Drawing on methods used to construct the Human Development Index (HDI), 53 we created a composite indicator, the Socio-demographic Index (SDI), based on equally weighted estimates of lagged distributed income (LDI) per person, average years of education among individuals older than 15 years, and total fertility rate. SDI was constructed as the geometric mean of these three values. SDI values were scaled to a range of 0-1, with 0 equalling measures of the lowest educational attainment, lowest income, and highest fertility between 1980 and 2015, and 1 equalling measures of the highest educational attainment, highest income, and lowest fertility during this time. SDI was computed for every geography-year under analysis, providing a populationlevel indicator of overall development at a given time. We tested whether alternative lags of the components of SDI would provide a better predictor of outcomes such as life expectancy and age-specifi c probabilities of death. We found that using LDI, educational attainment, and the total fertility rate in the current year is the most predictive of these mortality outcomes. The appendix provides additional detail on SDI computation (appendix pp 23, 24) and additional information can be found elsewhere. 
Decomposing change in under-5 mortality rate by causes of death
Based on the age-specifi c, sex-specifi c, and cause-specifi c mortality results from GBD 2015, 14 we attributed changes in under-5 mortality rate between 1990 and 2015 to changes in leading causes of death in children younger than 5 years during the same period. To do this, we applied the decomposition method developed by BeltranSanchez and colleagues, 54 which has also been used for other GBD analyses. 14, [43] [44] [45] 
Uncertainty analysis
We propagated known measures of uncertainty through key steps of the mortality estimation processes, including uncertainty associated with varying sample sizes of data, source-specifi c adjustments to data used for all-cause mortality, model specifi cations for spatiotemporal Gaussian Process regression (ST-GPR) and cause-specifi c model specifi cations, and estimation procedures. Uncertainty estimates were derived from 1000 draws for under-5 mortality, age-specifi c mortality, and cause-specifi c mortality by sex, year, and geography from the posterior distribution of each step of the estimation process. These draws allowed us to quantify, and then propagate, uncertainty for all mortality metrics. Percent changes and annualised rates of change were calculated between mean estimates, while the uncertainty intervals associated with the percent changes were derived from the 1000 draws.
Role of the funding source
The funder had no role in study design, data collection, data analysis, data interpretation, or manuscript writing and submission for publication. The corresponding author had full access to all data in the study and final responsibility to submit the paper.
Results
Trends in child mortality and by age group
Between 1990 and 2015, global under-5 deaths decreased by 52·0% (95% UI 50·7-53·3), from 12·1 million (12·0-12·2) in 1990 to 5·8 million (5·7-6·0) in 2015 (table 1). Reductions in total deaths were similar for the post-neonatal and childhood (age 1-4 years) age groups, each decreasing at least 50% between 1990 and 2015; deaths in children aged 1-4 years fell most rapidly during this time (by 59·8%, 95% UI 57·8-61·6). Neonatal deaths fell at a slower pace, decreasing 42·4% (41·3-43·6) from 4·6 million (4·5-4·6) in 1990 to 2·6 million (2·6-2·7) In 2015, age-specifi c mortality rates and total under-5 deaths varied by region and country ( 
MDG4 achievement and pace of progress
Absolute reductions in under-5 mortality at the global level equated to a 3·0% (2·6-3·3) annualised rate of 32 of the countries and territories that achieved MDG4 were classifi ed as lower-middle income or upper-middleincome countries by the World Bank, and only four of those that met MDG4 (Cambodia, Ethiopia, Liberia, and Nepal) were categorised as low-income countries. Figure 2 shows annualised rates of decrease in under-5 mortality from 2000 to 2015, starting at the time the 42·8% (29·4-54·6) and 51·9% (49·6 -54·2), respectively. These decreases continued for lower respiratory infections, diarrhoeal diseases, and tetanus, although the percent decrease over the most recent decade was not as high as in the previous 15 years; a similar trend was found for under-5 injury deaths, particularly for road injuries. Under-5 deaths due to measles, however, fell Egypt   11  15  19  23  27  31  35  39  43  47  51  55  59  63  67  71  75  79  83  87  91  95  99 103 regional trends emerged. For many high-income countries that already had under-5 mortality rates lower than 20 per 1000 livebirths in 1990, decreasing mortality due to neonatal disorders and congenital anomalies led to even lower under-5 mortality by 2015. In places known for their marked gains in overall development since 1990 (eg, China, Iran, Bhutan, and the Maldives), large reductions in death rates due to several causes-preterm birth complications, congenital anomalies, lower respiratory infections, and injuries-led to these countries' equally sizeable decreases in under-5 mortality. For Latin America and several countries in southeast Asia, progress in under-5 mortality was associated mainly with decreasing death rates from lower respiratory infections, diarrhoeal diseases, measles, and preterm birth complications. Decreasing malaria mortality rates served as the main force behind overall decreases in under-5 mortality for several countries in sub-Saharan Africa. In Uganda, Mozambique, Malawi, and Burundi, reductions in under-5 malaria deaths accounted for at least 35% of their total decreases in under-5 mortality. Several countries in sub-Saharan Africa, including Niger, Mali, Benin, and Liberia, could also attribute their improvements in child survival to reduced mortality from nutrition defi ciencies; however, such progress was generally far exceeded by the gains made against infectious diseases. Unlike higherincome countries, mortality rates due to neonatal disorders decreased at a much slower pace in sub-Saharan Africa, and thus minimally contributed to overall reductions in under-5 mortality. Across countries and territories under analysis, only three geographies (Dominica, Fiji, and Guam) had overall increases in under-5 mortality between 1990 and 2015; nonetheless, in some other countries, high rates of mortality due to HIV/AIDS or war lessened the potential for even greater gains for child survival since 1990. For example, in Lesotho, decreases in under-5 mortality due to diarrhoeal diseases and lower respiratory infections were almost completely counteracted by the country's toll of HIV/AIDS. The eff ects of war on child survival were evident for Syria and Yemen, where rising war-related deaths off set large decreases in under-5 mortality due to diarrhoeal diseases and lower respiratory infections.
SDI and under-5 mortality at regional and global levels
In view of the strong association between SDI and under-5 mortality, we examined regional trends for under-5 mortality and SDI to identify where progress was faster or slower than would be expected based on changes in SDI alone over time. In fi gure 5, each point represents a successive year from 1990 to 2015, refl ecting trends in observed and expected under-5 mortality for each GBD 85  93 101  111  121  131  141  151  161  171  181  191  201  211  221  231  241  251  261  271  281 region. The black line denotes expected levels of under-5 mortality based on rising SDI alone, which means that estimates above the black line are higher than expected given measures of SDI, and those below are lower than expected based on SDI alone. For higher-income regions, observed under-5 mortality generally followed expected trends over time and with increasing SDI. Western Europe and highincome Asia Pacifi c consistently recorded under-5 mortality rates that were somewhat lower than expected, based on SDI, whereas high-income North America posted slightly higher under-5 mortality rates than expected over time and given SDI. After experiencing under-5 mortality equalling or above expected rates given SDI in the 1990s, several regions, including Andean, Central, and tropical Latin America, as well as north Africa and the Middle East, had under-5 mortality rates falling below expected levels based on SDI by 2015; such progress was especially pronounced for Andean Latin America. Observed under-5 mortality consistently exceeded expected levels, based on rising SDI, in the Caribbean and central Asia, whereas under-5 mortality rates fell increasingly below expected levels for Oceania. Under-5 mortality trends and their relation to increasing SDI diverged across regions in sub-Saharan Africa.
Although observed levels of under-5 mortality exceeded expected rates in central and eastern sub-Saharan Africa in the 1990s, both regions saw marked reductions in observed under-5 mortality over time and experienced under-5 mortality rates far below expected levels by 2015; however, on average, these regions were still among those with the lowest levels of SDI in 2015. Notably, under-5 mortality in central sub-Saharan Africa largely decreased during a period of time when SDI decreased in the region. For western and southern subSaharan Africa, observed under-5 mortality remained higher than expected levels from 1990-2015, although increasing SDI in western sub-Saharan Africa corresponded with observed under-5 mortality rates moving closer to expected levels. In southern subSaharan Africa, under-5 mortality rose between 1995 and 2005, despite increasing SDI, fuelled by the escalating HIV/AIDS epidemic. Observed rates of under-5 mortality substantially decreased from 2006 to 2015, yet southern sub-Saharan Africa's levels of under-5 mortality still exceeded expected rates given its SDI during that time period.
With increasing SDI, expected levels and composition of under-5 mortality shifted in a noticeable pattern; fi gure 6 depicts these trends as assessed across geographies and over time, representing the average relationship between expected causes of under-5 mortality along measures of SDI. At the lowest levels of SDI, communicable causes, especially lower respiratory infections and diarrhoeal diseases, accounted for most under-5 deaths. Nutritional defi ciencies and neonatal disorders, which kill thousands of children under 5 worldwide, comprised a smaller proportion of overall deaths at the lowest levels of SDI. Even a moderate rise in SDI led to large absolute reductions in under-5 death rates and marked changes in cause composition. Under-5 deaths due to malaria and measles plummeted with gradual increases in SDI, highlighting the substantial eff ects of development for a subset of diseases. At the same time, mortality due to neonatal disorders accounted for an increasing proportion of under-5 deaths; reductions in mortality from lower respiratory infections are slower as well. By an SDI of 0·75, infectious diseases led to very few under-5 deaths. At this level of SDI, neonatal disorders and congenital anomalies accounted for the majority of under-5 deaths, though overall deaths were quite low.
SDI and child mortality at country, territory, and subnational levels
Distinctive, but highly heterogeneous, patterns emerged across and within regions when we compared observed under-5 mortality rates and annualised rates of change to expected levels and pace of change for under-5 mortality given SDI in 2015. Figure 7 shows the ratios of observed and expected under-5 mortality by geography in 2015, colour coded by the magnitude of diff erences between observed and expected under-5 mortality.
Geographies where the ratio of observed and expected under-5 mortality fell well below 1·00 were mainly in Central America, many states in Brazil, east and southeast Asia, and western Europe. A subset of countries in north Africa and the Middle East (eg, 0·44 in Palestine and 0·43 in Morocco), and eastern sub-Saharan Africa (eg, 0·57 for Ethiopia and 0·65 for Mozambique) also had lower levels of observed under-5 mortality than expected given SDI. Turkmenistan, Guam, and Azerbaijan had the highest ratios for observed and expected under-5 mortality, each exceeding a ratio of 3·00. There was also a high level of heterogeneity at the subnational level. In Kenya, 14 of 47 counties had levels of under-5 mortality in 2015 that were well below what was expected given their SDI while seven counties experienced levels that were somewhat higher than expected. In China, 30 of 33 provinces and municipalities recorded ratios equal to or below 1·00, highlighting countrywide gains in under-5 mortality, whereas all subnational geographies in the USA and South Africa had higher levels of observed under-5 mortality than expected rates based on SDI. We also noted geographic diff erences between observed and expected annualised rates of change for under-5 mortality between 2000 and 2015. Of the 195 countries and territories assessed, 125 had annualised rates of decline that were faster than expected based on change in SDI alone. Compared with expected rates of change, observed rates of annualised decline were generally faster in subSaharan Africa and throughout the Asia Pacifi c. Exceptions included Chad and Lesotho in sub-Saharan Africa, and Malaysia in southeast Asia. The appendix further illustrates these diff erences (appendix p 39). 
Expected changes in under-5 mortality due to SDI
Stillbirths
Worldwide, 2·1 million (1·8-2·5) stillbirths occurred in 2015, representing a 47·0% (35·1-57·0) decrease from 4·0 million (3·1-5·2) in 1990. In view of the fact that livebirths worldwide have increased slightly from 138·6 million to 140·6 million during the same time, the decrease in number of stillbirths is all the more encouraging. Stillbirth rates decreased 47·0% (35·6-56·8) during this time, declining from 28·1 per 1000 (21·8-36·4) in 1990 to 14·9 per 1000 (12·8-17·6) in 2015. Figure 9 displays stillbirth rates across geographies in 2015, which ranged from 1·2 per 1000 (1·0-1·5) in Iceland to 56·3 per 1000 (32·3-98·2) in South Sudan. Western and central sub-Saharan Africa recorded among the highest stillbirth rates, with eight countries experiencing rates exceeding 25 per 1000 in 2015. South and southeast Asia saw stillbirth rates span from 3·4 per 1000 (2·6-4·5) in Thailand to 27·6 per 1000 (23·1-32·8) in Pakistan. In Europe, nine countries documented stillbirth rates lower than two per 1000, whereas no country or territory in the Americas had stillbirth rates 
Discussion
Since its establishment in 2000, MDG4 has been viewed as a major catalyst for heightened political, social, and fi nancial commitments to improve child survival, and specifi cally, to reduce under-5 mortality by two-thirds by 2015. Yet the duration of assessment for MDG4 spanned 1990 MDG4 spanned -2015 a decision that ultimately aff ected which countries could be considered on pace-equalling or exceeding an annualised rate of decline of 4·4%-to achieve this target. As part of the GBD 2015 study, we identifi ed 58 countries that met or surpassed this threshold between 1990 and 2015, and 36 were deemed to be low-income, lower-middleincome, or upper-middle-income countries. By contrast, from 2000-15, 73 countries reached or exceeded this pace of decline, and many more were in subSaharan Africa. However, amid these gains, 23 countries still reported under-5 mortality rates exceeding 75 deaths per 1000 livebirths in 2015, three times higher than the recently proposed SDG target for 2030. 41 Further, while absolute diff erences between countries with the lowest and highest rates of child survival have narrowed since 1990, by 2015, under-5 mortality still ranged from fewer than two deaths per 1000 livebirths in Andorra to more than 130 deaths per 1000 livebirths in Chad. These fi ndings emphasise the pressing need to better assess how various factors may accelerate or hinder progress for reducing under-5 mortality.
As a novel extension of GBD 2015 analyses, we assessed global trends in under-5 deaths, in terms of what we recorded and what we could have expected solely on the basis of SDI. From 1990-2000, global trends in under-5 deaths were consistent with improving levels of SDI. The high correlation recorded for SDI and under-5 deaths, which was found across geographies during this time, was probably mediated through several pathways, including improved access to and demand for public health services and medical care, and reduced risks for various childhood diseases, including malnutrition, poor water and unsafe sanitation, and pollution. 55 However, from 2000 onwards, we observed greater gains in reducing under-5 deaths than what would be expected in view of increases in SDI alone. This accelerated pace of progress led to 10·3 million fewer under-5 deaths since 2000, a time that marked a new era focused on improving child health.
Such hastened, faster-than-anticipated gains in survival and longevity have been studied previously, including Preston's attribution of shifts in the association between life expectancy and income per person to technical innovations 10 and several studies that identify medical technologies or health-sector research and development activities as the main, if not singular, drivers of reduced mortality. 13, 30, 56 Alternatively, such gains also have been accredited to increased investments in child health programmes, 22 as well as packages of cost-eff ective interventions targeting disorders that disproportionately aff ect children. 10, 13 Recent analyses show that accelerated reductions in under-5 mortality can be traced to the scale-up of multiple health interventions since 2000, including insecticide-treated nets, prevention of mother-to-child transmission of HIV, and the introduction of new vaccines, alongside improved indicators of socio-economic development. 57 The timing of such gains in child survival from 2000-15, which far exceeded the expected pace of progress based on improved SDI, cannot be ignored, as this progress directly coincided with an escalated policy focus onand development assistance allocated to-child health.
Many factors probably underpin these fi ndings, and they should be thoroughly examined in future studies; based on our current analyses and data, we cannot reliably parse out and attribute decreases in under-5 mortality to specifi c interventions, health policies, or the intersection of heightened development and health system performance by geography. Here we delve further into GBD 2015 fi ndings for child mortality, specifi cally as they relate to the MDG4 era, changes in SDI, and changes in causespecifi c mortality in children younger than 5 years.
MDG4 and the future of improving child survival
To chart potential pathways for achieving continued reductions in under-5 mortality, as well as the proposed SDG goals for child survival, it is of immense value to examine where and why particular countries have decreased under-5 mortality, and at faster rates, than gains in SDI alone would predict. Costa Rica and Cuba, which are heralded as model countries for elevating both income and health outcomes since the 1990s, 13 achieved lower levels of under-5 mortality than expected on the basis of SDI alone by 2015; however, their pace of progress in reducing under-5 mortality from 2000 to 2015 was slower than expected based on increases in SDI. Chile and China, the other two countries that comprise the lauded 4Cs, 13 also recorded lower-than-expected levels of under-5 mortality in 2015, particularly China; in terms of their annualised rates of change for under-5 mortality since 2000, nearly every province and municipality in China saw the pace of declining under-5 mortality exceed expected rates, whereas Chile's rate of decline was somewhat slower than expected on the basis of SDI. In combination, these examples stress the importance of assessing both absolute levels and relative pace of progress when identifying country outliers in performance.
For GBD 2015, four low-income countries-Cambodia, Ethiopia, Liberia, and Nepal-met or exceeded the MDG4 annualised pace of decrease for both time periods (1990-2015 and 2000-2015) , representing several success stories for improving child health. As shown by our decomposition analyses, substantial reductions in under-5 deaths due to lower respiratory infections and diarrhoeal diseases contributed decreases in overall under-5 mortality across these four countries. Further, in Ethiopia, decreasing under-5 deaths due to measles and nutritional defi ciencies also were major factors in improving child survival, which might be related to the country's implementation of accelerated measles control strategies during the 2000s 58 and continued eff orts to address historical challenges with malnutrition. 59 The group of low-income countries that met or exceeded the MDG4 pace of decrease since 2000 markedly grew, also including Malawi, Niger, Rwanda, Tanzania, and Zambia, which provides concrete evidence that rapid decreases in under-5 mortality are achievable, even in lower-resource settings. Within countries known for subnational inequalities, including Brazil and Kenya, observed rates of decrease in under-5 mortality in some regions (eg, northeast Brazil; western and southern areas of Kenya) highlight the potential for progress amid long-standing disparities. It is an unlikely coincidence that many of these geographies also recorded lower under-5 levels in 2015 and faster rates of decrease since 2000 than expected based on SDI. MDG4 country case studies highlight the importance of multi-sectoral approaches to improving child health, [60] [61] [62] such as implementing policies to achieve universal access to primary care for women and children, increasing overall government spending on maternal and child health, and enacting programmes that promote educational attainment and empowerment among women. Expanded cases studies examining the drivers of faster-than-expected reductions in under-5 mortality, particularly among countries of similar SDI, could provide powerful examples of policy and fi nancing options to sustain, and accelerate, gains in child survival in the post-MDG era.
In moving from MDG4 to SDG3.2, targets for child survival also shift from a focus on relative progress to achieving absolute targets. By 2015, we found that 120 countries already recorded under-5 mortality rates below 25 per 1000 livebirths, and 118 countries had neonatal mortality rates under the target of 12·5 per 1000 livebirths. Some of the remaining countries, including Mali, Chad, and the Central African Republic, experienced levels of under-5 mortality exceeding 125 per 1000 livebirths in 2015; to achieve SDG3.2 by 2030, these countries would need to reduce their under-5 mortality at a rate faster than 10% per year. Such large, continuous reductions in under-5 mortality are essentially unprecedented in recent decades, with the exception of a few counties in China. 32 Subsequently, the pursuit and potential achievement of SDG3.2 depends on sustained, targeted investments and long-term commitments to enabling policy environments. In an era of stagnating development assistance for health and relatively weak prospects for sizeable growth for domestic health fi nancing in low-income countries, 22, 23 depending on elevated funds as the primary accelerant of child survival will likely leave many countries short of achieving SDG3.2 by 2030. Instead, the combination of continuing investments in proven, high-impact child health programmes, including immunisation pro grammes and malaria interventions, targeting development assistance for health to countries with the highest child mortality rates, and establishing innovative fi nancing mechanisms and effi ciency gains is crucial.
Changes in under-5 causes of death and their contribution to reducing under-5 mortality
By 2015, global under-5 deaths from the vast majority of causes markedly decreased, yet their relative pace of decrease varied substantially from 1990-2005 and 2005-15. For some causes, including measles, tetanus, diarrhoeal diseases, and lower respiratory infections, large decreases in under-5 deaths occurred during both time periods. Such sustained gains may be related to the continued expansion of routine immunisation programmes, reduced exposure to risks such as poor sanitation and household air pollution, 55 and improved access to health services and care-seeking behaviours for childhood illnesses, particularly in lower-income countries. 63 Additionally, increasingly more high-burden countries have introduced new vaccines, 64 such as pneumococcal conjugate vaccine and the rotavirus vaccine, all of which have likely contributed to decreases in under-5 deaths due to lower respiratory infections and diarrhoea. Despite these gains, however, lower respiratory infections remain a leading cause of under-5 death in many low-income and middle-income countries, underscoring the importance of addressing underlying risks for lower respiratory infections and heightened lower respiratory infection mortality (eg, various types of pollution and malnutrition), 65, 66 as well as improving access to timely diagnosis and treatment.
Global Trends and eff ects of congenital anomalies, neonatal conditions, and injuries on under-5 mortalityessentially non-infectious causes of child death-varied by region and country income level. For higher-income countries, where under-5 mortality rates were already quite low in 1990, decreases in deaths due to preterm birth complications, various neonatal disorders, and congenital anomalies accounted for the vast majority of gains by 2015. These trends are likely related to improvements in medical technologies and access to intensive neonatal care. By contrast, in lower-income settings, health facilities often are not fully equipped and staff ed to treat complex neonatal conditions, 69 and when they are, other barriers to care, such as cost and travel time to facilities, may prevent some of the highest risk women from seeking critical health services. 70 Eff ective interventions and services exist to prevent many of these conditions, 71 or at minimum avert premature death from them, including multiple antenatal care visits and case management of neonatal sepsis; 37 however, they often require multifaceted medical care or policy options that, at present, are not fully funded or prioritised by development partners and national governments alike.
For many upper-middle-income and lower-middleincome countries, overall and relative decreases in under-5 mortality were quite heterogeneous. In some countries, such as Bangladesh, decreasing deaths due to drowning contributed to reductions in under-5 mortality since 1990, refl ecting the likely implementation of policies that address heightened risks for these unintentional injuries. 72 Declining under-5 deaths due to congenital anomalies were associated with improved child survival in countries such as the Maldives and Iran, but for many countries in Latin America, including Brazil, minimal changes occurred for under-5 deaths due to these causes. Further, in some Latin American countries, such as Colombia and Venezuela, under-5 mortality rates from congenital anomalies slightly increased by 2015, albeit not signifi cantly so. In light of the region's current Zika virus outbreak and its potential to spread to other geographies, 73, 74 improved monitoring of congenital anomalies, both in terms of mortality and incidence, is of high priority.
By examining the cause composition of under-5 mortality across levels of SDI, we can consider the optimal suite of interventions that are most relevant to a geography's progression of development. At the lowest levels of SDI, the dominance of infectious diseases (namely diarrhoeal diseases, lower respiratory infections, malaria, and measles) and nutritional defi ciencies underscores the potential impact of scaling up interventions targeting these causes, particularly in terms of accelerating gains in child survival beyond expected rates based on SDI. Particularly for the lowest two quintiles for SDI, several eff ective public health strategies exist for further reducing under-5 mortality, 20, 75 including the introduction and scale-up of new and long-standing vaccines (ie, pneumococcal conjugate vaccine, rotavirus, and measles); expanding access to oral rehydration therapy and antibiotics; increasing the proper use of various malaria interventions, including insecticide-treated nets and artemisinin-based comb ination therapies; and addressing nutritional defi ciencies through supplementation and the promotion of exclusive breastfeeding. By contrast, for geographies in the second and third quintiles of SDI, neonatal conditions accounted for the majority of under-5 deaths. This characterisation, framing epidemiological transitions in terms of under-5 mortality and SDI, uniquely captures the importance of neonatal causes and their toll on child survival as amid gains in development. To reach the very low levels of under-5 mortality achieved by many high-income countries (ie, less than fi ve deaths per 1000 livebirths), eff ectively treating and preventing neonatal conditions are obstacles that countries will need to clear with increasing SDI.
Stillbirths
Amid gains in under-5 and neonatal mortality, moderate progress also occurred for reducing the world's burden of stillbirths. Globally, total stillbirths decreased 47·0% (35·1-57·0%) since 1990, decreasing from 4·0 million (3·1-5·2 million) in 1990 to 2·1 million (1·8-2·5 million) in 2015, and stillbirth rates dropped from 28·1 per 1000 (21·8-36·4 per 1000) to 14·9 per 1000 (12·8-17·6 per 1000) during this time. Such reductions, particularly in countries such as Brazil, have been associated with improved access to antenatal care and addressing known maternal risks for stillbirth. 40 While specifi c risks for stillbirth may vary by country and within countries (eg, the distribution of genetic risk for congenital conditions are likely to diff er across regions and local communities), the commonalities in risk profi les experienced across these high-burden countries (ie, large rural populations with low access or utilisation of antenatal care and skilled birth attendance, as well as the inadequate detection and treatment of maternal conditions during pregnancy) cannot be ignored. 40 In comparing GBD 2015 stillbirth fi ndings with those published by the Stillbirth Epidemiology Investigator Group (SEIG), 39, 40 we found that our results are highly correlated with previous estimates for 2000 and 2015 (0·891). At the country level, however, the average relative diff erence between GBD and SEIG estimates for 2015 was -31·3%, indicating that GBD stillbirth results were generally lower than those produced by SEIG. Relative diff erences ranged from -321·3% to 64·8%, with 49 countries experiencing absolute diff erences in their point estimates that exceeded 50%. Notably, countries for which the largest diff erences occurred between GBD and SEIG were rarely those with the highest stillbirth rates. Diff erences in point estimates for stillbirths mainly emerged from the use of divergent modelling strategies; in particular, for GBD, we applied a unifi ed modelling strategy that drew from consistent, comparably generated covariates across geographies and over time. Further, we used sourcetype fi xed eff ects and source-specifi c random eff ects nested within each country in order to properly account for potential non-sampling biases from diff erent data sources. In combination, these methods allowed us to generate an internally consistent times series of total and rates of stillbirths across geographies.
As emphasised by others, 39, 40 many countries with the highest stillbirth burdens have limited data systems documenting stillbirths and existing sources are prone to biases. Further, we found that extensive crosswalking across the eight stillbirth defi nitions encountered in our analysis, as well as adjusting for non-sampling bias for data sources, had substantial eff ects on stillbirth estimation at various geographic levels. This further demonstrates the critical importance of more standard data collection and synthesis approaches for stillbirths, particularly as we collectively seek to better quantify local burdens of stillbirth and identify cost-eff ective options for their prevention.
Comparing GBD and IGME estimates
In recent years, both the GBD and IGME have produced annual assessments of trends in child mortality. 1, 2, 5, 6, 76 GBD 2015 estimates and the most recent estimates from IGME are highly correlated (0·983) across the 187 countries and time period they both cover; however, for some countries, there are notable diff erences. In comparing absolute values of mean relative diff erences for estimates of under-5 mortality between GBD 2015 and IGME, we found a mean absolute relative diff erence of 20·4% in 2015, normalised to the GBD 2015 estimates. The range of country-level relative diff erences is much larger. Absolute relative diff erences in 2015 between the two organisations' estimates exceeded 20% for 74 countries and were between 10% and 20% in 43 countries. While our estimates were correlated (0·768), and we identifi ed a similar quantity of countries achieving MDG4 (ie, 59 from IGME and 58 from GBD), variation emerged in terms of which countries actually met the target by 2015. 42 countries were identifi ed as achieving MDG4 by both GBD and IGME, whereas 16 countries were acknowledged as having achieved MDG4 by GBD but not by IGME, and 17 countries were categorised as achieving MDG4 by IGME but not by GBD (the appendix provides a detailed comparison). Results for sub-Saharan Africa were especially discrepant, as we identifi ed only two countries, Ethiopia and Liberia, having achieved MDG4 between 1990 and 2015, and IGME reported ten countries reaching MDG4 (Eritrea, Ethiopia, Liberia, Madagascar, Malawi, Mozambique, Niger, Rwanda, Tanzania, and Uganda). 5 In view of the recorded variations across estimates, and the uncertainty associated with estimating annualised rates of change, we recommend judicious interpretation of particular claims about the achievement or nonachievement of MDG4.
Such diff erences in estimates stem from a number of factors. First, our approaches to data processing diff er. In GBD, methods are used to calculate under-5 mortality rates from summary birth histories, 1,77 which consist of four diff erent modelling strategies as informed by characteristics of the raw data composing the summary birth histories. These improved methods address two main shortcomings of previous summary birth history methods, which are still currently used by IGME and other organisations: 5, 6 unstable estimates of under-5 mortality for the years immediately before survey data collection; and the short span of time covered by estimates. We have subjected our summary birth history models to extensive validation testing, which documents the improved accuracy of our methods for analysing summary birth history data. 77 Second, there are notable diff erences in the modelling strategies used by GBD and IGME. Developed during the 2013 iteration of GBD, we apply a data bias adjustment before ST-GPR, which is the modelling step from which fi nal estimates and corresponding 95% uncertainty intervals are generated. This adjustment allows us to correct for non-sampling biases from each data source within each country upon designating reference sources.
1
Reference source selection is informed by documentation of data quality and insights provided by the extensive GBD network of collaborators.
Improving child mortality data coverage and quality
Data quantity and quality for under-5 mortality, especially in low-income and middle-income countries, has steadily improved over the past three decades; nonetheless, most available data for under-5 mortality in these settings are derived from survey instruments and do not originate from fully functional, complete VR systems. In recent years, honed methods for extracting and synthesising measures of under-5 mortality from surveys, especially summary birth modules, and subnational health information systems have supported more accurate, timely generation of under-5 estimates. 1, 77 However, in the absence of VR data, high levels of uncertainty accompany these measures and the risk of biased estimates persists. For monitoring agespecifi c mortality and stillbirths, these measurement challenges are only amplifi ed, as the quantity and standardisation of data collection for these indicators are much lower. SDG targets call for improved data monitoring for countries, including an indicator that refers to the need for birth registration, a key component of VR systems, for all populations by 2030. 41 Increased and sustained investments in building and maintaining complete VR systems, especially in LMICs, have the potential to strengthen responsiveness to and accountability for continuing to improve child health in the post-MDG era.
Limitations
Amid its strengths and methodological advances, the present study has several limitations. First, although the quantity of data available to estimate under-5 mortality is quite high for most countries, potential for bias exists across the various data sources. We have sought to account for these biases by identifying the highest quality reference source for each country and adjusting estimates from other sources accordingly. Nonetheless, bias might remain for selected reference data sources. Second, less data are available to systematically disaggregate estimates of under-5 mortality into age-specifi c values for early neonatal, late neonatal, post-neonatal, and ages 1-4 years by geography and year; subsequently, age-specifi c results in many countries are more model dependent. A similar limitation applies to stillbirth estimation. Third, limitations associated with cause-specifi c estimation, as detailed in an accompanying publication, 14 apply to our decomposition analyses for attributing changes in causes of death to changes in under-5 mortality. Fourth, due to computational constraints, we were unable to fully propagate uncertainty associated with covariates used to estimate cause-specifi c mortality and so-called garbage code redistribution algorithms. Sensitivity analyses for under-5 mortality indicate that the omission of uncertainty estimates from the fi rst-stage model covariates did not signifi cantly alter fi nal estimates of under-5 mortality. Fifth, results evaluated in terms of SDI, such as ratios for observed and expected under-5 mortality, may be aff ected by the potential for measurement error in the individual components comprising SDI (ie, income per person, educational attainment, and total fertility rate). However, because it is comprised of three inputs, our SDI indicator will be less sensitive to measurement error than placing countries on the development continuum using income per person alone, and the improved correlation coeffi cient between SDI and under-5 mortality as compared with income per person alone provides further support to this idea. Sixth, our assessment of observed trends in under-5 deaths, as compared with expected trends based on SDI alone, cannot provide causal attribution. Rather, this examination resulted in a strong empirical correlation and provides a useful framework from which to benchmark levels and trends of under-5 deaths, taking into account where a geography is along the development continuum.
Our summary measure of SDI included key components of sociodemographic development, but it is possible that, in some contexts, other indicators may be more strongly linked to under-5 mortality, and thus the correlation between SDI and under-5 mortality may vary. Seventh, our estimation of stillbirth rates makes use of many data sources from low-income and middle-income countries that are facility based. Stillbirths from these sources are likely to be biased upwards because of women with high-risk pregnancies or diffi cult labour being more likely to go to a facility. In addition, there may be location-specifi c variations in the eff ect of diff erent case defi nitions. We have attempted to systematically correct for this bias, but this correction is based on statistical analysis and not on detailed studies in each location. Eighth, our analyses could not account for the full range of inequalities that might be experienced within countries and subnational administrative areas. We have substantially increased the number of subnational geographies for GBD 2015, but further expansion hinges upon greater data availability and stakeholder interest in leading subnational GBD analyses. In future iterations of the GBD, we hope to further examine the eff ects of more localised measures of inequality, particularly for income and other socioeconomic factors, on child health outcomes across geographies. And lastly, as with other estimations of under-5 mortality and stillbirth rates, our estimates for the most recent years are based on extrapolation using our data synthesis models due to data availability. As new data from surveys and censuses become available, our estimates in the future will certainly be aff ected.
Conclusion
Global achievements in improving child survival serve as one of the most notable success stories in recent times, signifying the eff ect of international collaboration and focus on ending preventable mortality. Although these gains have been near universal across geographies, the pace of progress varied markedly, especially in terms of what could be expected based on corresponding improvements in overall development. Accelerated, faster-than-anticipated reductions in under-5 mortality occurred between 2000 and 2015 in many lower-income countries, highlighting the crucial role of scaling up eff ective child health interventions above and beyond sociodemographic advances. Large decreases in under-5 deaths due to many infectious diseases contributed to reductions in under-5 mortality, strengthening the evidence base for tackling these lethal, preventable conditions that disproportionately aff ect the poor. Overall neonatal mortality, death due to specifi c neonatal causes and congenital anomalies, and stillbirths moderately decreased, but such gains were mainly concentrated in higher-income countries. In evaluating shifts in composition of under-5 mortality across epidemiological transitions, the persistent toll of neonatal conditions, especially as countries moved from low levels of development and eff ectively reduced under-5 deaths from infectious diseases, is clear. The prioritisation of funding and programmes that address the risks for neonatal death and stillbirths will probably emerge as a vital need for countries where reductions in under-5 mortality have stagnated or occurred at a slower pace than expected given their level of development. As the world shifts away from the MDG era and toward the SDGs, we must draw from lessons learned from countries where child survival has improved the fastest and design targeted, eff ective strategies to accelerate reductions in child mortality for the places with the furthest to go.
